Viewing StudyNCT00389675

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:06 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00389675
Status: TERMINATED
Last Update Posted: 2014-01-06
First Post: 2006-10-17
Brief Title: DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study Protocol DAR-312 of Darusentan in Resistant Hypertension
Sponsor: Gilead Sciences
Organization: Gilead Sciences
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Hypertension
Keywords: